Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIK
#3371
Anika Therapeutics Inc. - Common Stock
21.1
0
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.25%
Monthly Change
+27.80%
6 month change
+46.94%
Year Change
+108.09%
Previous Close
20.8
4
Open
21.1
0
Low
21.1
0
High
21.1
0
Volume
35
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
ANIK
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
14.33 M
14.47 M
14.63 M
14.85 M
14.18 M
13.4 M
13.38 M
Valuation ratios
Enterprise value
552.74 M
423.97 M
345.05 M
263.63 M
177.71 M
71.3 M
247.22 M
Price to earnings ratio
-26.78
127.96
-28.9
-4.02
-4.3
-12.64
-79.05
Price to sales ratio
4.93
3.55
2.75
1.99
2.02
1.22
—
Price to cash flow ratio
49.27
62.44
97.36
-185.74
44.85
12.32
54.47
Price to book ratio
2.36
1.83
1.5
1.56
1.57
0.96
0.53
Enterprise value to EBITDA ratio
11.81
5.18
5.96
-26.72
3.99
1.63
—
Profitability ratios
Return on assets %
-0.07
0.01
-0.04
-0.31
-0.28
-0.06
0.02
Return on equity %
-0.09
0.01
-0.05
-0.39
-0.37
-0.08
0.02
Return on invested capital %
-50.18
1.3
-28.3
-200.62
20.05
-51.44
8.94
Gross margin %
52.91
56.12
59.89
61.85
63.38
56.56
65.15
Operating margin %
-21.71
1.77
-12.42
-52.58
-4.25
-9.8
9.06
EBITDA margin %
35.89
55.42
37.05
-5.92
37.12
38.79
48.51
Net margin %
-18.38
2.8
-9.51
-49.6
-47.02
-9.64
10.15
Liquidity ratios
Quick ratio
3.56
4.45
4.65
3.76
3.85
3.86
3.19
Current ratio
4.81
5.66
6.07
5.26
4.88
4.72
4.48
Inventory turnover
1.8
1.58
1.65
1.48
1.25
2.61
0.4
Asset turnover
0.37
0.41
0.45
0.54
0.51
0.59
0.18
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.92
0.57
0.3
-0.12
0.37
0.78
0.39
EBIT per share
2.33
4.61
2.97
-1.64
2.64
2.65
2.89
EBITDA per share
3.29
5.6
3.98
-0.67
3.02
3.05
3.33
Total debt per share
—
—
—
—
—
—
—
Cash per share
6.91
6.45
8.31
7.43
5.38
5.66
2.8
Net current asset value per share
12.47
11.52
11.64
11.14
7.72
7.21
7.23
Tangible book value per share
19.15
19.62
19.61
14.48
10.46
10.01
10.01
Working capital per share
9.88
9.48
9.73
9.02
6.14
5.68
5.62
Book value per share
19.15
19.62
19.61
14.48
10.46
10.01
10.01
News
ORKA Stock Up More Than 60% in 3 Months: Here's What You Should Know
Best Momentum Stocks to Buy for August 26th
J&J's Imaavy Gets FDA Approval as the First Treatment for wAIHA
GSK's sBLA for Jemperli Gets FDA Priority Tag in Rectal Cancer
Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why
Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
Aurinia Settles Voclosporin Patent Litigation With Teva, Stock Rises
MRK/MRNA's Personalized Cancer Therapy Delivers First Phase III Win
AMLX Rises as Avexitide Nears 2026-End Filing With Phase III Study Win
BioMarin Inks $490M Deal to Buy Rare Bone Disease Treatment
5 Stocks With Recent Price Strength to Enhance Your Portfolio Returns
MESO Completes Patient Treatment in Chronic Back Pain Study, Stock Up